Showing 13 to 24 of 80 results
Novo Nordisk Offers $499 Ozempic to US Patients
Novo Nordisk is offering a monthly supply of Ozempic for $499 to US patients who pay out-of-pocket, responding to President Trump's calls to lower drug costs and addressing sales impacts from compounding pharmacies.
Novo Nordisk Offers $499 Ozempic to US Patients
Novo Nordisk is offering a monthly supply of Ozempic for $499 to US patients who pay out-of-pocket, responding to President Trump's calls to lower drug costs and addressing sales impacts from compounding pharmacies.
Progress
40% Bias Score
Novo Nordisk's Share Price Plummets Amidst Increased Competition and Market Challenges
Novo Nordisk's share price plummeted over 50 percent this year due to increased competition from Eli Lilly's Mounjaro, the prevalence of cheaper compounded GLP-1 drugs, and slower adaptation to market changes, leading to a significant loss in market value and a CEO change.
Novo Nordisk's Share Price Plummets Amidst Increased Competition and Market Challenges
Novo Nordisk's share price plummeted over 50 percent this year due to increased competition from Eli Lilly's Mounjaro, the prevalence of cheaper compounded GLP-1 drugs, and slower adaptation to market changes, leading to a significant loss in market value and a CEO change.
Progress
56% Bias Score
Counterfeit Weight-Loss Drugs: A Global Health Threat
The high demand for weight-loss injections like Ozempic has led to a surge in counterfeit drugs, posing significant health risks; one in ten medicines globally are counterfeit, according to the WHO, with online sales exacerbating the problem.
Counterfeit Weight-Loss Drugs: A Global Health Threat
The high demand for weight-loss injections like Ozempic has led to a surge in counterfeit drugs, posing significant health risks; one in ten medicines globally are counterfeit, according to the WHO, with online sales exacerbating the problem.
Progress
40% Bias Score
Forged Prescriptions for Weight-Loss Drugs Rise in Northern Germany
Criminals in northern Germany are forging prescriptions for weight-loss medications like Ozempic and Wegovy, exploiting high demand fueled by social media trends and celebrity endorsements; the introduction of e-prescriptions is reducing but not eliminating the problem, leaving pharmacies financiall...
Forged Prescriptions for Weight-Loss Drugs Rise in Northern Germany
Criminals in northern Germany are forging prescriptions for weight-loss medications like Ozempic and Wegovy, exploiting high demand fueled by social media trends and celebrity endorsements; the introduction of e-prescriptions is reducing but not eliminating the problem, leaving pharmacies financiall...
Progress
36% Bias Score
MHRA Investigates Link Between GLP-1 Drugs and Pancreatitis
The UK's MHRA is investigating a possible link between GLP-1 weight-loss drugs and pancreatitis, prompting a review of 560 cases, although current data doesn't indicate rates exceeding those in clinical trials; experts warn against unregulated use.
MHRA Investigates Link Between GLP-1 Drugs and Pancreatitis
The UK's MHRA is investigating a possible link between GLP-1 weight-loss drugs and pancreatitis, prompting a review of 560 cases, although current data doesn't indicate rates exceeding those in clinical trials; experts warn against unregulated use.
Progress
44% Bias Score
UK Weight-Loss Injections Linked to Pancreatitis Cases
Over a million people in the UK have used weight loss and diabetes jabs, with the Medicines and Healthcare products Regulatory Agency (MHRA) reporting 294 cases of pancreatitis (inflammation of the pancreas) linked to these drugs, including five deaths. A new study will investigate genetic links.
UK Weight-Loss Injections Linked to Pancreatitis Cases
Over a million people in the UK have used weight loss and diabetes jabs, with the Medicines and Healthcare products Regulatory Agency (MHRA) reporting 294 cases of pancreatitis (inflammation of the pancreas) linked to these drugs, including five deaths. A new study will investigate genetic links.
Progress
48% Bias Score
Counterfeit Weight-Loss Drugs: A Global Health Crisis
The high demand for weight-loss drugs like Ozempic has created shortages, leading to a surge in counterfeit medications globally, with the World Health Organization estimating 10% of medicines are fake; this is fueled by compounding pharmacies and exacerbated by inadequate consumer awareness.
Counterfeit Weight-Loss Drugs: A Global Health Crisis
The high demand for weight-loss drugs like Ozempic has created shortages, leading to a surge in counterfeit medications globally, with the World Health Organization estimating 10% of medicines are fake; this is fueled by compounding pharmacies and exacerbated by inadequate consumer awareness.
Progress
44% Bias Score
Weight-Loss Injections Increase Surgical Death Risk
A London-based plastic surgeon warns that the widespread use of weight-loss injections in the UK is creating an increased risk of death during surgery due to delayed gastric emptying, causing aspiration pneumonia, and emphasizes the need for patients to inform doctors about their usage.
Weight-Loss Injections Increase Surgical Death Risk
A London-based plastic surgeon warns that the widespread use of weight-loss injections in the UK is creating an increased risk of death during surgery due to delayed gastric emptying, causing aspiration pneumonia, and emphasizes the need for patients to inform doctors about their usage.
Progress
60% Bias Score
Counterfeit Weight-Loss Drugs: A Global Health Crisis
The global demand for weight-loss drugs like Ozempic has created shortages, leading to a surge in counterfeit medications; the WHO estimates 10% of medicines worldwide are fake, posing significant health risks, while challenges in regulating compounding pharmacies exacerbate the problem.
Counterfeit Weight-Loss Drugs: A Global Health Crisis
The global demand for weight-loss drugs like Ozempic has created shortages, leading to a surge in counterfeit medications; the WHO estimates 10% of medicines worldwide are fake, posing significant health risks, while challenges in regulating compounding pharmacies exacerbate the problem.
Progress
40% Bias Score
GLP-1 Agonists Show Significant Dementia Risk Reduction
A large Irish study of 164,531 participants found that GLP-1 agonists, like Ozempic and Wegovy, reduced dementia risk by 45 percent, potentially offering a preventative measure for both diabetes and dementia, conditions on the rise in the US.
GLP-1 Agonists Show Significant Dementia Risk Reduction
A large Irish study of 164,531 participants found that GLP-1 agonists, like Ozempic and Wegovy, reduced dementia risk by 45 percent, potentially offering a preventative measure for both diabetes and dementia, conditions on the rise in the US.
Progress
44% Bias Score
Spain Investigates Novo Nordisk for Potentially Illegal Weight-Loss Drug Advertising
Spain is investigating Novo Nordisk for potentially illegal advertising of its weight-loss drugs Ozempic and Wegovy, following similar accusations in Ireland and the UK, prompting concerns about pharmaceutical marketing tactics and their impact on national health budgets.
Spain Investigates Novo Nordisk for Potentially Illegal Weight-Loss Drug Advertising
Spain is investigating Novo Nordisk for potentially illegal advertising of its weight-loss drugs Ozempic and Wegovy, following similar accusations in Ireland and the UK, prompting concerns about pharmaceutical marketing tactics and their impact on national health budgets.
Progress
48% Bias Score
Novo Nordisk's Obesity Campaign Backfires Amidst Public Outrage
Novo Nordisk's Madrid campaign, labeling obesity a deadly disease, sparked controversy due to its aggressive tone and perceived promotion of Ozempic, despite support from some scientific societies who now express concern.
Novo Nordisk's Obesity Campaign Backfires Amidst Public Outrage
Novo Nordisk's Madrid campaign, labeling obesity a deadly disease, sparked controversy due to its aggressive tone and perceived promotion of Ozempic, despite support from some scientific societies who now express concern.
Progress
60% Bias Score
Showing 13 to 24 of 80 results